FibroGen - FGEN Operatsion rentabellik

fibrogen.com (FGEN) kompaniyasining korporativ logotipi

FibroGen, Inc. (FGEN) kompaniyasining operatsion marjasidagi o'zgarish yangi dori vositalarini sinovdan o'tkazishdagi muvaffaqiyatsizliklar va patent nizolari bilan bog'liq xatarlarning ta'sirini ko'rsatmoqda. Daromadlar barqarorligi fibroz va anemiya davolash vositalarining sotuvi bilan ta'minlanmoqda. Biroq, -458.60 kapitalni saqlab qolish uchun rahbariyatni shtatni qisqartirishga va restrukturizatsiyani amalga oshirishga majbur qilgan naqd pul tanqisligi fonidagi ushbu ko'rsatkichning joriy darajasini aks ettiradi.

FGEN: fibrogen.com Operatsion foyda bo'yicha marjinallik 04.07.2022 - 08.01.2026

FibroGen (FGEN) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning fundamental baholanishi:FibroGen Corporation, FGEN
fibrogen.com asosiy tovari

Operatsion marja xarajatlarni boshqarish samaradorligini aks ettiradi va moliyaviy xarajatlar hamda soliqlardan oldingi umumiy daromadning operatsion foyda ulushini ifodalaydi. Operatsion marja tebranishlarini tahlil qilish orqali investor FibroGen, Inc. (FGEN) kompaniyasining ichki barqarorligini baholaydi, bu esa AQSh dagi barqaror muhit va sog'liqni saqlash sektorining gumanitar maqomi bilan qo'llab-quvvatlanib, geosiyosiy risklarning biznes daromadliligiga ta'sirini minimallashtiradi.

Raqobatchilar tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.